Cargando…

BTG1 potentiates apoptosis and suppresses proliferation in renal cell carcinoma by interacting with PRMT1

B-cell translocation gene 1 (BTG1) is a member of the BTG/transducer of Erb family. BTG1 regulates cell cycle progression, inhibits proliferation, promotes apoptosis and stimulates cellular differentiation in multiple cell types. However, the functions of BTG1 in renal cell carcinoma (RCC) remain un...

Descripción completa

Detalles Bibliográficos
Autores principales:	LIU, CHUNHUI, TAO, TAO, XU, BIN, LU, KAI, ZHANG, LEI, JIANG, LIANG, CHEN, SHUQIU, LIU, DACHUANG, ZHANG, XIAOWEN, CAO, NIHAO, CHEN, MING
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2015
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4513370/ https://www.ncbi.nlm.nih.gov/pubmed/26622543 http://dx.doi.org/10.3892/ol.2015.3293

Ejemplares similares

PRMT5 promotes cell proliferation by inhibiting BTG2 expression via the ERK signaling pathway in hepatocellular carcinoma
por: Jiang, Hai, et al.
Publicado: (2018)

Deletion of Btg1 Induces Prmt1-Dependent Apoptosis and Increased Stemness in Shh-Type Medulloblastoma Cells Without Affecting Tumor Frequency
por: Ceccarelli, Manuela, et al.
Publicado: (2020)

Tumor suppressor BTG1 promotes PRMT1-mediated ATF4 function in response to cellular stress
por: Yuniati, Laurensia, et al.
Publicado: (2015)

BTG2 suppresses renal cell carcinoma progression through N6-methyladenosine
por: Qi, Fuming, et al.
Publicado: (2022)

Emerging role of antiproliferative protein BTG1 and BTG2
por: Kim, Sang Hyeon, et al.
Publicado: (2022)

miR-27a-3p regulates proliferation and apoptosis of colon cancer cells by potentially targeting BTG1
por: Su, Chang, et al.
Publicado: (2019)

Tumor suppressors BTG1 and BTG2: Beyond growth control
por: Yuniati, Laurensia, et al.
Publicado: (2018)

MicroRNA-328 directly targets p21-activated protein kinase 6 inhibiting prostate cancer proliferation and enhancing docetaxel sensitivity
por: LIU, CHUNHUI, et al.
Publicado: (2015)

Targeted Deletion of Btg1 and Btg2 Results in Homeotic Transformation of the Axial Skeleton
por: Tijchon, Esther, et al.
Publicado: (2015)

The roles of BTG1 mRNA expression in cancers: A bioinformatics analysis
por: Zheng, Hua-chuan, et al.
Publicado: (2022)

UHRF1 suppresses retrotransposons and cooperates with PRMT5 and PIWI proteins in male germ cells
por: Dong, Juan, et al.
Publicado: (2019)

RNA binding protein PUM2 promotes hepatocellular carcinoma proliferation and apoptosis via binding to the 3′UTR of BTG3
por: Liu, Zhenhua, et al.
Publicado: (2022)

BTG1 Expression Correlates with the Pathogenesis and Progression of Ovarian Carcinomas
por: Zhao, Yang, et al.
Publicado: (2013)

PRMT1 loss sensitizes cells to PRMT5 inhibition
por: Gao, Guozhen, et al.
Publicado: (2019)

PRMT1 mediated methylation of cGAS suppresses anti-tumor immunity
por: Liu, Jing, et al.
Publicado: (2023)

Hypoxia preconditioned renal tubular epithelial cell-derived extracellular vesicles alleviate renal ischaemia-reperfusion injury mediated by the HIF-1α/Rab22 pathway and potentially affected by microRNAs
por: Zhang, Lei, et al.
Publicado: (2019)

TEAD4 modulated LncRNA MNX1-AS1 contributes to gastric cancer progression partly through suppressing BTG2 and activating BCL2
por: Shuai, You, et al.
Publicado: (2020)

BTG2 bridges PABPC1 RNA-binding domains and CAF1 deadenylase to control cell proliferation
por: Stupfler, Benjamin, et al.
Publicado: (2016)

PRMT1 is an important factor for medulloblastoma cell proliferation and survival
por: Gu, Xiao, et al.
Publicado: (2022)

Overexpression of PRMT6 does not suppress HIV-1 Tat transactivation in cells naturally lacking PRMT6
por: Sivakumaran, Haran, et al.
Publicado: (2013)

PRMT1 is a novel molecular therapeutic target for clear cell renal cell carcinoma
por: Wang, Jianfeng, et al.
Publicado: (2021)

Ribonucleic acid-binding protein CPSF6 promotes glycolysis and suppresses apoptosis in hepatocellular carcinoma cells by inhibiting the BTG2 expression
por: Liu, Yang, et al.
Publicado: (2021)

Upregulation of miR-146a by YY1 depletion correlates with delayed progression of prostate cancer
por: Huang, Yeqing, et al.
Publicado: (2017)

MiR-25-3p promotes the proliferation of triple negative breast cancer by targeting BTG2
por: Chen, Hua, et al.
Publicado: (2018)

PRMT7 targets of Foxm1 controls alveolar myofibroblast proliferation and differentiation during alveologenesis
por: He, Huacheng, et al.
Publicado: (2021)

BTG1 inhibits malignancy as a novel prognosis signature in endometrial carcinoma
por: Li, Yibing, et al.
Publicado: (2020)

The Suppressive Role and Aberrent Promoter Methylation of BTG3 in the Progression of Hepatocellular Carcinoma
por: Lv, Zhenbing, et al.
Publicado: (2013)

MiR-21 Protected Cardiomyocytes against Doxorubicin-Induced Apoptosis by Targeting BTG2
por: Tong, Zhongyi, et al.
Publicado: (2015)

Crystal structures of human BTG2 and mouse TIS21 involved in suppression of CAF1 deadenylase activity
por: Yang, Xiuna, et al.
Publicado: (2008)

Protein arginine methyltransferases PRMT1, PRMT4/CARM1 and PRMT5 have distinct functions in control of osteoblast differentiation
por: Dashti, Parisa, et al.
Publicado: (2023)

A conserved motif in human BTG1 and BTG2 proteins mediates interaction with the poly(A) binding protein PABPC1 to stimulate mRNA deadenylation
por: Amine, Hamza, et al.
Publicado: (2021)

TINCR inhibits the proliferation and invasion of laryngeal squamous cell carcinoma by regulating miR-210/BTG2
por: He, Guoqing, et al.
Publicado: (2021)

MiRNA-543 promotes osteosarcoma cell proliferation and glycolysis by partially suppressing PRMT9 and stabilizing HIF-1α protein
por: Zhang, Heng, et al.
Publicado: (2016)

BTG4 is A Novel p53 Target Gene That Inhibits Cell Growth and Induces Apoptosis
por: Zhang, Na, et al.
Publicado: (2020)

Elevated BTG2 improves the radiosensitivity of non‐small cell lung cancer (NSCLC) through apoptosis
por: Zhu, Changchun, et al.
Publicado: (2022)

SUV39H2/KMT1B Inhibits the cardiomyocyte senescence phenotype by down-regulating BTG2/PC3
por: Wang, Kan, et al.
Publicado: (2021)

PRMT1 suppresses ATF4-mediated endoplasmic reticulum response in cardiomyocytes
por: Jeong, Myong-Ho, et al.
Publicado: (2019)

Chidamide triggers BTG1-mediated autophagy and reverses the chemotherapy resistance in the relapsed/refractory B-cell lymphoma
por: Xue, Kai, et al.
Publicado: (2021)

SENP1 prevents steatohepatitis by suppressing RIPK1-driven apoptosis and inflammation
por: Yan, Lingjie, et al.
Publicado: (2022)

PRMT1-mediated EZH2 methylation promotes breast cancer cell proliferation and tumorigenesis
por: Li, Zhongwei, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_stpr0i1emajphk5qa135keod27